| Literature DB >> 34762359 |
Lukas Anton Wein1, Klaus Wurst2, Thomas Magauer1.
Abstract
Herein, we present our studies to construct seven ent-trachylobane diterpenoids by employing a bioinspired two-phase synthetic strategy. The first phase provided enantioselective and scalable access to five ent-trachylobanes, of which methyl ent-trachyloban-19-oate was produced on a 300 mg scale. During the second phase, chemical C-H oxidation methods were employed to enable selective conversion to two naturally occurring higher functionalized ent-trachylobanes. The formation of regioisomeric analogs, which are currently inaccessible via enzymatic methods, reveals the potential as well as limitations of established chemical C-H oxidation protocols for complex molecule synthesis.Entities:
Keywords: Biomimetic synthesis; C−H activation; Natural products; Terpenoids; Total synthesis
Year: 2021 PMID: 34762359 PMCID: PMC7612322 DOI: 10.1002/anie.202113829
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336
Figure 1Structures of selected ent-trachylobanes and C-H oxidations of the carbon framework.
Scheme 1Total syntheses of ent-trachylobanes, reagents and conditions
a) Pd/C, H2, AcOH, EtOAc, 23 °C, 8 d, 73 %; b) NaH, then MeOCHO, THF–PhMe, 0 °C to 23 °C, 4 h; c) MVK, NEt3, CH2Cl2, 23 °C, 48 h, then NaOMe, MeOH, 23 °C, 24 h, 41% over two steps; d) LiHMDS, then MeI, THF, -50 °C to 23 °C, 25 h, 80 %; e) LDA, TMEDA, then MeCHO, THF, –20 °C then –78 °C, 3 h, 99 %; f) Martin sulfurane, PhH–CH2Cl2, 23 °C, 3 h, 85 %; g) NaBH4, CeCl3·7H2O, MeOH, 0 °C, 2 h, 76 %; h) Burgess reagent, DME, 75 °C, 2 h, 40 %; i) PhMe, 175 °C, 9 h, 85 %; j) Mn(dpm)3, PhSiH3, t-BuOOH, /-PrOH, 23 °C, 4 h, 99 %; k) NaH, EtSH, DMF, 120 °C, 3 h, 99 %; l) NaH, EtSH, DMF, 120 °C, 4 h, 99 %; m) Red-Al®, PhMe, –20 °C to 23 °C, 22 h, 98 %; n) PPh3, I2, imidazole, PhMe, 60 °C, 3 h, 49 %; o) Pd/C, H2, NaOAc, MeOH, 23 °C, 16 h, 94 %.
Scheme 2C–H oxidations of ent-trachylobanes 15, 6, and 17, reagents and conditions
a) TFDO, CH2Cl2, 0 °C, 3 h, 43 % for 18; b1) (+)RVC foam/(-)Ni, Me4NBF4, quinuclidine, air, HFIP, MeCN, constant current, 23 °C, 36 % for 18, 10 % for 20, 29 % for 3; b2) Ru(TMP)(CO) (21), 2,6-dichloropyridine-N-oxide, CH2Cl2, 65 °C, 27 % for 18, 28 % for 19, 20 % for 3; c) (R,R)-Mn(CF3-PDP) (24), aq. H2O2, TfOH, TFE, 0 °C, 75 min, 30 %; d) I2, PIDA, hν (mercury vapor lamp), CyH, 23 °C, 2 h, 28 %; e) PCC, CH2Cl2, 0 °C to 23 °C, 3 h, 99 %; f) 2-picolylamine, p-TsOH ·H2O, PhMe, 80 °C, 16.5 h, 99 %; g) Cu(NO3)2·3 H2O, H2O2, THF, 50 °C, 4.5 h; h) Ac2O, DMAP, pyridine, 23 °C, 8 h (32 % over two steps).